What comes before model selection?

A clear intended use, defined users, excluded uses and the human decision points.

What makes deployment safer?

Representative evaluation, documented hazards, monitored performance and usable escalation.

Responsible clinical AI

Clinician-controlled AI starts with clear boundaries

Q: Who remains responsible?

Qualified professionals and deploying organisations retain clinical and operational accountability.

Useful is not the same as safe. Intended use, human review, evidence, consent and uncertainty must remain visible.

Clear intended use Human accountability Safe escalation

NivaCare editorial teamPublished 29 July 20267 minute read

AI can organise, draft and surface patterns. Trust depends on knowing exactly what it is intended to do, where it may fail and who remains responsible.

Read the perspective All insights

From fragmented tools to one care journeyNivaCare adapts to your workflow.

Old waySix disconnected tools

Separate booking, telehealth, messaging, EHR, laboratory and analytics systems.

Multiple fees · Multiple logins · Data silos · More complexity

NivaCare wayOne connected care platform

One login, unified clinical context, better insights and continuous patient care.

One platform · One subscription · One longitudinal journey

Useful is not the same as safe

A feature may save time in a demonstration and still be unsuitable for clinical deployment. Health software must be evaluated in its intended workflow, with the actual users, language, population, devices and consequences of error considered.

Five questions to ask before deployment

1. What is the intended use?

Define the user, task, care setting and exclusions. “AI for healthcare” is not an intended use. “Preparing a consultation note draft for clinician review” is closer to one.

2. Where is human review?

Review should be meaningful, not ceremonial. The clinician needs enough context to detect errors, understand uncertainty and change or reject the output.

3. What evidence supports this version?

Performance can change with language, setting, population, input quality and software version. Evaluation should match the deployed version and intended environment.

4. How are consent and data governed?

Patients should understand what information is used and why. Access, retention, sharing and withdrawal processes should match the purpose and applicable requirements.

5. What happens when the system is uncertain?

Low-confidence outputs, missing information and high-risk situations need a defined escalation path. Automation must not hide ambiguity.

A practical deployment pattern

NivaCare describes mental wellbeing voice analysis and treatment-response simulation as investigational concepts requiring governed validation. Neither is presented as autonomous diagnosis, prescription or a guaranteed prediction.

Map one workflow and one intended benefit.
Document hazards, exclusions and human approval points.
Evaluate technical performance, usability and bias.
Pilot with oversight and pre-agreed measures.
Monitor versions, drift, incidents and user feedback.

Reference points and related reading

How connected care reduces gaps ABDM and patient-controlled health records NivaCare Evidence & Safety Centre WHO guidance on ethics and governance of AI for health CDSCO medical devices and software information